COVID-19: NEW PARADIGMS FOR DISEASE MANAGEMENT
Journal: Indian Drugs (Vol.57, No. 03)Publication Date: 2020-03-28
Authors : Vandana B. Patravale;
Page : 5-6
Keywords : ;
Abstract
Dr. Vandana B. Patravale is currently a Professor of Pharmaceutics at the Institute of Chemical Technology, Mumbai, India. Her areas of research include development of nano-carriers with major emphasis on malaria, cancer and neurodegenerative disorders; medical device development, nano-diagnostics and nano-vaccines. She has over 200 refereed publications, 11 granted patents, 24 patents in pipeline and 2 trademark registries. She has published 2 books and 25 book chapters with international publishers. Dr. Patravale has been active in teaching, research and service throughout her career. She was awarded the Kukreja Oration award 2020, APTI's Dr. Manjushree Pal Best Pharmaceutical Scientist Award 2019, Shri Amrut Mody distinguished researcher award 2018, OPPI women scientist award 2015, Bill Melinda Gates grant award 2015, Best Pharmaceutical Scientist award 2014, VASVIK award 2013, Veneto nanotech award 2013, APTI best teacher award 2012, Fellowship of Maharashtra Academy of Sciences, 2011 and K.H. Garda Distinguished researcher award 2009.
Other Latest Articles
- DEVELOPMENT AND VALIDATION OF STABILITY INDICATING METHOD FOR IPRATROPIUM BROMIDE BY USING RP-HPLC
- DETECTION OF IMIDACLOPRID RESIDUES IN SPINACH BY HPLC AND ITS EFFECT ON ANTIOXIDANT ACTIVITY
- Formulation and evaluation of Lipstick, Rouge and Eye shadow using colored pigment from the extract of Piper betel and Acacia catechu
- SIMULTANEOUS ESTIMATION OF DOXORUBICIN AND HYDROxyCHAVICOL IN BULK AND PHARMACEUTICAL FORMULATION BY Q-ABSORPTION RATIO METHOD
- APPLICATION OF CHEMOMETRIC METHODS FOR DETERMINATION OF CLOTRIMAZOLE AND BECLOMETHASONE DIPROPIONATE IN PHARMACEUTICAL DOSAGE FORM
Last modified: 2020-05-15 18:46:18